Relato de Caso: Síndrome de Vogt-Koyanagi-Harada / Case Report: Vogt-Koyanagi-Harada Syndrome

Gustavo Coelho Caiado, Rodrigo Crispim Dompieri, Valéria Barcelos Daher, Valeriana de Castro Guimarães


Vogt–Koyanagi–Harada (VKH) disease is an inflammatory and autoimmune condition characterized by panuveitis, serous retinal detachments, and extraocular manifestations of the auditory, integumentary, and central nervous systems (CNS). Early diagnosis and prompt and adequate treatment with immuno-suppressive agents (corticosteroids and other immunosuppressive drugs) may halt disease progression and prevent recurrences and vision loss. The purpose of this article is to report a case of VKH.


multifocal choroiditis, serous retinal detachment, panuveitis, corticosteroid, VKH.


Baltmr A, Lightman S, Tomkins-Netzer O. Vogt-Koyanagi-Harada syndrome – current perspectives. Clinical Ophtalmology 2016:10 2345-2361.

Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Progress in retinal and eye research 52 (2016) 84-111.

Patil YB, et al. Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals. J Family Med Prim Care. 2020 Jan; 9(1): 31-35.

Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes- Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652.

Silpa-archa S, Silpa-archa N, Preble JM, Foster CS. Vogt-Koyanagi-Harada syndrome: perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity reviews 15 (2016) 809-819.



  • There are currently no refbacks.